Q1 2024 Holdings
Filed 2024-05-14 | 26 holdings | $389.9M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Liberty Broadband Corp(LBRDK) | COM SER C | 530307305 | $108.0M | 1,886,260 | 27.7% |
| Springworks Therapeutics Inc | COM | 85205L107 | $29.2M | 592,528 | 7.5% |
| Ascendis Pharma A/S(ASND) | SPONSORED ADR | 04351P101 | $26.6M | 175,672 | 6.8% |
| Arvinas Inc(ARVN) | COM | 04335A105 | $22.3M | 539,100 | 5.7% |
| Revolution Medicines Inc(RVMD) | COM | 76155X100 | $21.8M | 677,100 | 5.6% |
| Sarepta Therapeutics Inc(SRPT) | COM | 803607100 | $20.5M | 158,457 | 5.3% |
| Argenx SE(ARGX) | SPONSORED ADR | 04016X101 | $19.7M | 50,000 | 5.0% |
| Moonlake Immunotherapeutics(MLTX) | CLASS A ORD | 61559X104 | $18.1M | 360,916 | 4.6% |
| Cytokinetics Inc(CYTK) | COM NEW | 23282W605 | $16.7M | 238,046 | 4.3% |
| Galapagos NV(GLPG) | SPON ADR | 36315X101 | $16.2M | 503,759 | 4.2% |
| Acadia Pharmaceuticals Inc(ACAD) | COM | 004225108 | $15.5M | 840,453 | 4.0% |
| Eyepoint Pharmaceuticals Inc(EYPT) | COM NEW | 30233G209 | $13.6M | 656,600 | 3.5% |
| Dish Network Corporation | NOTE 12/1 | 25470MAF6 | $13.5M | $18,300,000 | 3.4% |
| Solid Biosciences Inc(SLDB) | COM NEW | 83422E204 | $12.8M | 961,251 | 3.3% |
| Travere Therapeutics Inc(TVTX) | COM | 89422G107 | $12.7M | 1,649,221 | 3.3% |
| Relay Therapeutics Inc(RLAY) | COM | 75943R102 | $12.4M | 1,490,170 | 3.2% |
| Prothena Corp PLC(PRTA) | SHS | G72800108 | $10.0M | 402,400 | 2.6% |
| Churchill Capital Corp VII | *W EXP 02/29/202 | 17144M110 | $175.4K | 548,000 | 0.0% |
| Moneyhero Limited | *W EXP 09/13/202 | G6202B119 | $108.5K | 895,000 | 0.0% |
| Calidi Biotherapeutics Inc | COM NEW | 320703101 | $70.6K | 125,000 | 0.0% |
| Concord Acquisition Corp II | *W EXP 99/99/999 | 20607U116 | $45.4K | 408,333 | 0.0% |
| Compass Digital Acquisition Corp(COMP) | *W EXP 09/29/202 | G2476C123 | $42.3K | 459,906 | 0.0% |
| Calidi Biotherapeutics Inc | *W EXP 03/14/202 | 320703119 | $34.1K | 655,200 | 0.0% |
| Swiftmerge Acquisition Corp | *W EXP 12/13/202 | G63836111 | $27.4K | 490,000 | 0.0% |
| YS Biopharma Co LTD | *W EXP 03/15/202 | G9845F117 | $25.0K | 489,999 | 0.0% |
| Marblegate Acquisition Corp | *W EXP 08/31/202 | 56608A113 | $8.2K | 735,000 | 0.0% |